| Literature DB >> 33808827 |
Efrat Emanuel1, Irina Dubrovin1, Roman Pogreb2, Gad A Pinhasi1, Rivka Cahan1.
Abstract
Pulsed electric fields (PEFs) technology was reported to be useful as a disinfection method in the liquid food industry. This technology may lead to membrane permeabilization and bacterial death. However, resuscitation of viable but non-culturable cells and sublethally injured microorganisms in food was reported to be associated with foodborne outbreaks. The main aim of this study was to investigate the possible recovery of injured PEF-treated bacteria. The PEF treatment of Staphylococcus aureus and Pseudomonas putida led to a reduction of 3.2 log10 and 4.8 log10, respectively. After 5 h, no colony forming units (CFUs) were observed when the bacteria were suspended in phosphate buffer saline (PBS); and for 24 h, no recovery was observed. The PEF-treated S. aureus in brain-heart infusion (BHI) medium were maintained at 1.84 × 104 CFU mL-1 for about 1.5 h. While P. putida decreased to zero CFU mL-1 by the 4th hour. However, after that, both bacteria recovered and began to multiply. Flow cytometry analysis showed that PEF treatment led to significant membrane permeabilization. Mass spectrometry analysis of PEF-treated P. putida which were suspended in BHI revealed over-expression of 22 proteins, where 55% were related to stress conditions. Understanding the recovery conditions of PEF-treated bacteria is particularly important in food industry pasteurization. To our knowledge, this is the first comprehensive study describing the recovery of injured PEF-treated S. aureus and P. putida bacteria.Entities:
Keywords: bacteria; conductivity; current density; eradication; pulsed electric fields
Year: 2021 PMID: 33808827 PMCID: PMC8003612 DOI: 10.3390/foods10030660
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Schematic drawing of the electroporator chamber: Side view (A,B); top view (C).
Figure 2CFU (colony forming unit) counts of S. aureus (A) and P. putida F1 (B) as a function of pulsed electric field (PEF)-treatment in different current densities. The control column and the second column (0.02 A cm−2) represent the CFU mL−1 of bacterial cells that were suspended in UP water without PEF-treatment and with PEF-treatment, respectively. The remaining columns (0.9–3.4 A cm−2) represent the CFU mL−1 that were suspended in solutions with different current densities. p-value (t-test): p < 0.05 *; p < 0.01 **; p < 0.001 ***.
Figure 3CFU mL−1 of PEF-treated and nontreated S. aureus (A) and P. putida F1 (B). PEF-treated bacteria in time ‘0’ (); non-treated bacteria in time ‘0’ (); PEF-treated bacteria in brain-heart infusion (BHI) (1.5–24 h) (); PEF-treated bacteria in phosphate buffer saline (PBS) (1.5–24 h) (); nontreated bacteria in BHI (1.5–24 h) (); non-treated bacteria in PBS (1.5–24 h) (). p value (t test): Significance of the CFU count in each examined time (PEF-treated bacteria in BHI or in BPS) related to its control (nontreated bacteria in BHI or PBS, respectively) p < 0.001 ***; significance of the CFU of the treated-bacteria in PBS related to treated-bacteria in BHI, in each examined time p < 0.01 ##; p < 0.001 ###.
Figure 4Membrane permeability of S. aureus (A) and P. putida F1 (B). PEF-treated bacteria which were diluted in BHI (1.5–24 h) (); PEF-treated bacteria which were suspended in PBS (0–24 h) (); nontreated bacteria which were diluted in BHI (1.5–24 h) (); nontreated bacteria which were suspended in PBS (0–24 h) (). Propidium iodide (PI)-positive control using ethanol was 90 ± 3%. p values (t-test): p < 0.05 *; p < 0.001 ***.
Figure 5FCM (flow cytometry) analysis of S. aureus relative cell size. (A–C) represent comparison between the PEF-treated and nontreated samples at selected times: (A)—‘0’ time; (B)—1.5 h; (C)—24 h. Nontreated cells in PBS-red; nontreated cells in BHI-orange; PEF-treated cells in BHI-green; PEF-treated cells in PBS-blue.
MS (mass spectrometry) analysis of the over-expressed proteins from PEF-treated P. putida F1, compared to the nontreated bacteria.
| Protein IDs | Protein Name | Gene Name | Mol. Weight [kDa] | log2 * LFQ Intensity Nontreated | log2 * LFQ Intensity PEF-Treated |
|---|---|---|---|---|---|
| A5W5H2 | Alkyl hydroperoxide reductase/Thiol specific antioxidant/Mal allergen | Pput_3256 | 20.507 | 28.96 ± 0.43 | 33.33 ± 0.33 |
| A5VXD9 | TonB-dependent siderophore receptor | Pput_0376 | 88.459 | 19.18 ± 1.94 | 24.63 ± 1.18 |
| A5W124 | TonB-dependent siderophore receptor | Pput_1678 | 90.426 | ND | 24.12 ± 0.28 |
| A5W341 | TonB-dependent siderophore receptor | Pput_2412 | 79.564 | ND | 21.21 ± 0.73 |
| A5VZF9 | Integral membrane sensor signal transduction histidine kinase | Pput_1108 | 70.283 | ND | 21.84 ± 1.71 |
| A5VWS0 | Probable proton/glutamate-aspartate symporter | gltP | 47.566 | 21.96 ± 0.55 | 25.61 ± 0.18 |
| A5VXU7 | OmpW family protein | Pput_0539 | 24.19 | ND | 26.06 ± 1.47 |
| A5W1U8 | ABC-type metal ion transport system periplasmic component/surface adhesin-like protein | Pput_1965 | 30.162 | 18.25 ± 2.17 | 22.68 ± 0.16 |
| A5W1V5 | Propeptide, PepSY and peptidase M4 | Pput_1972 | 44.145 | ND | 24.35 ± 1.01 |
| A5VZG2 | L-glutamate ABC transporter membrane protein/L-aspartate ABC transporter membrane protein | Pput_1111 | 27.45 | 17.90 ± 1.57 | 22.14 ± 1.10 |
| A5W312 | Deoxyribonuclease I | Pput_2383 | 35.477 | ND | 21.05 ± 0.18 |
| A5WA94 | Choline/carnitine/betaine transporter | Pput_4934 | 73.501 | 20.91 ± 0.14 | 24.61 ± 0.52 |
Note: * Since a t-test must be done on normally distributed data, thus mass-spectrometry data is log-normalized, we applied log2 transformation to the (label-free quantitation) LFQ intensities.